ABVX — Abivax SA News Story

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

All News

Abivax shares sink after key trial results for inflammatory bowel drug

Abivax SA

02/06/2026 08:19

Abivax shares sink after key trial results for inflammatory bowel drugJune 2 (Reuters) - Abivax ABVX.PA shares tumbled 26% on Tuesday after the French biotech company unveiled the highly anticipated results of the late-stage trial for its inflammatory bowel drug the night before.

(Reporting by Gianluca Lo Nostro; Editing by Milla Nissi-Prussak)
((gianluca.lonostro@thomsonreuters.com;))

ABVX — Abivax SA News Story

Abivax shares sink after key trial results for inflammatory bowel drug

Recent news on Abivax SA

Brief: Euronext Includes Maurel et Prom, Mersen In SBF 120, Excludes Elior Group, Nexity

Abivax shares sink after key trial results for inflammatory bowel drug (updated)

Abivax shares sink after key trial results for inflammatory bowel drug

Abivax seen falling up to 25% after key trial for inflammatory bowel drug

Abivax's inflammatory bowel drug meets main goal of late stage trial